The Trend Of High Returns At IRadimed (NASDAQ:IRMD) Has Us Very Interested
The Trend Of High Returns At IRadimed (NASDAQ:IRMD) Has Us Very Interested
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. And in light of that, the trends we're seeing at IRadimed's (NASDAQ:IRMD) look very promising so lets take a look.
要找到一只多袋股票,我们应该在一家企业中寻找什么潜在趋势?理想情况下,一家企业将呈现两种趋势;第一,增长退货关于已使用资本(ROCE),第二,增加金额已动用资本的比例。如果你看到这个,通常意味着它是一家拥有出色商业模式和大量有利可图的再投资机会的公司。有鉴于此,我们看到的趋势IRadimed的(纳斯达克:irmd)看起来很有前途,所以让我们来看看。
Return On Capital Employed (ROCE): What Is It?
资本回报率(ROCE):它是什么?
If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. The formula for this calculation on IRadimed is:
如果你以前没有使用过ROCE,它衡量的是一家公司从业务资本中获得的“回报”(税前利润)。IRadimed上的此计算公式为:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
已动用资本回报率=息税前收益(EBIT)?(总资产-流动负债)
0.24 = US$17m ÷ (US$81m - US$7.6m) (Based on the trailing twelve months to June 2023).
0.24美元=1700万美元(8100万美元-760万美元)(根据截至2023年6月的往绩12个月计算)。
Therefore, IRadimed has an ROCE of 24%. That's a fantastic return and not only that, it outpaces the average of 9.7% earned by companies in a similar industry.
所以呢,IRadimed的净资产收益率为24%。这是一个惊人的回报,不仅如此,它还超过了类似行业公司9.7%的平均回报率。
See our latest analysis for IRadimed
查看我们对IRadimed的最新分析
![roce](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20231013/0-ca78c39940985091aa2bcfab1f58183c-0-35145355e0d16423cce1564f308dd7dd.png/big)
In the above chart we have measured IRadimed's prior ROCE against its prior performance, but the future is arguably more important. If you're interested, you can view the analysts predictions in our free report on analyst forecasts for the company.
在上面的图表中,我们对比了IRadimed之前的ROCE和它之前的表现,但可以说,未来更重要。如果您感兴趣,您可以在我们的免费分析师对该公司的预测报告。
What Can We Tell From IRadimed's ROCE Trend?
我们能从IRadimed的ROCE趋势中看出什么?
IRadimed is displaying some positive trends. The numbers show that in the last five years, the returns generated on capital employed have grown considerably to 24%. The amount of capital employed has increased too, by 93%. So we're very much inspired by what we're seeing at IRadimed thanks to its ability to profitably reinvest capital.
IRadimed正在显示出一些积极的趋势。这些数字显示,在过去五年中,资本回报率大幅增长至24%。所使用的资本额也增加了93%。因此,我们对IRadimed所看到的非常鼓舞人心,这要归功于它能够有利可图地进行资本再投资。
The Bottom Line
底线
A company that is growing its returns on capital and can consistently reinvest in itself is a highly sought after trait, and that's what IRadimed has. Since the stock has returned a solid 49% to shareholders over the last five years, it's fair to say investors are beginning to recognize these changes. With that being said, we still think the promising fundamentals mean the company deserves some further due diligence.
一家资本回报率不断增长、能够持续对自身进行再投资的公司是一个备受追捧的特征,而这正是IRadimed所拥有的。过去五年,该公司股票的股东回报率高达49%,可以说,投资者开始意识到这些变化。话虽如此,我们仍然认为,前景看好的基本面意味着该公司值得进行进一步的尽职调查。
If you'd like to know more about IRadimed, we've spotted 2 warning signs, and 1 of them makes us a bit uncomfortable.
如果你想了解更多关于iRadimed的信息,我们已经发现2个警示标志,其中的一个让我们有点不舒服。
If you'd like to see other companies earning high returns, check out our free list of companies earning high returns with solid balance sheets here.
如果您想看到其他公司获得高回报,请查看我们的免费这里列出了资产负债表稳健、获得高回报的公司。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。